Morgan Stanley maintains Constellation Brands stock rating amid volume concerns

Constellation Brands (STZ) is facing significant short-term and long-term volume pressures, including evolving consumer preferences, macroeconomic headwinds, and increased competition, which have contributed to a 26% stock decline over six months. Ahead of its Q1 earnings, analysts have offered varied outlooks: Morgan Stanley reiterated an Equalweight rating with a $195 target, suggesting many concerns are largely priced into the current valuation, while UBS lowered its EPS forecast below consensus and several firms adjusted price targets. Despite these headwinds, the company maintains strong dividend growth, and a recent positive market reaction to potential changes in U.S. drinking guidelines offers a counterpoint to the prevailing pressures.

Analysis

Constellation Brands (STZ) is confronting significant, multi-faceted pressures on its core beer business, contributing to a stock decline of over 26% in the past six months. According to Morgan Stanley, the challenges are both structural and cyclical. Long-term headwinds include secular shifts in consumer behavior, such as growing health consciousness, cannabis substitution, and lower alcohol consumption among younger demographics. These are compounded by company-specific issues, including a maturing brand portfolio evidenced by soft buy rates across all income brackets and demographics, suggesting the weakness is not isolated to macroeconomic factors. In the short term, the company faces macroeconomic headwinds, unfavorable weather, and strengthening competition from Anheuser-Busch InBev. Ahead of its fiscal first-quarter earnings, analyst sentiment is cautious; UBS forecasts earnings per share of $3.15, below the consensus of $3.41, and multiple firms including UBS, Evercore ISI, and BofA Securities have recently lowered their price targets. Evercore specifically anticipates a slight decline in beer depletions and higher marketing expenses in the first half of fiscal 2026. Despite this, Morgan Stanley suggests these negative factors are now largely priced into the stock's valuation. Positive attributes noted in the data include a strong dividend growth rate of 14.61% and a low beta of 0.7, indicating some financial resilience.

Key Decisions for Investors

• Given the stock's 26% pullback and Morgan Stanley's view that headwinds are largely priced in, investors should weigh the depressed valuation against the significant near-term risks heading into the Q1 earnings report.
• Monitor the upcoming earnings call for specific data on beer depletion rates, management's outlook on the Hispanic consumer segment, and the margin impact of the expected increase in marketing spend.
• Long-term investors should assess if the company's strong dividend growth of 14.61% and potential regulatory tailwinds are sufficient to offset the structural risks from changing consumer preferences and competition.
• Consider the competitive landscape, as improved market share for Anheuser-Busch InBev represents a direct headwind for Constellation Brands' volume growth.